Status:
COMPLETED
Covid-19 Rapid Diagnostic Tests on Blood Drop
Lead Sponsor:
CMC Ambroise Paré
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
This study will evaluate the diagnostic reliability of the Biosynex rapid blood test for Covid-19 infection.
Detailed Description
The Covid-19 pandemic requires a reliable diagnosis of affected patients in order to manage them in an appropriate manner, in the appropriate departments. Furthermore, the diagnostic reference at the ...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 diagnosis with at least one positive RT-PCR
Exclusion
- None
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2020
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT04467008
Start Date
July 15 2020
End Date
August 15 2020
Last Update
November 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CMC Ambroise Paré
Neuilly-sur-Seine, France, 92200